Coexpression of PD-L1/PD-1 with CXCR3/CD36 and IL-19 Increase in Extranodal Lymphoma

Figure 4

ROC curves of PD-L1/PD-1 coexpression with CXCR3/CD36 and IL-19 to predict extranodal involvement in lymphoma. (a) Pretherapy CXCR3+%. (b) Pretherapy PD-L1+CXCR3+%. (c) Pretherapy PD-1+CXCR3%. (d) Pretherapy IL-19.

(a)

(b)

(c)

(d)